Osteoid osteoma treated with percutaneous radiofrequency ablation: MR imaging follow-up

Min Hee Lee, Joong Mo Ahn, Hye Won Chung, Hyo K. Lim, Jae Gon Suh, Hyon Joo Kwag, Hyun Pyo Hong, Byung Moon Kim

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Purpose: We evaluated follow-up magnetic resonance (MR) images for osteoid osteoma treated with percutaneous radiofrequency ablation (RFA). Materials and methods: Sixteen patients with osteoid osteoma treated with RFA underwent follow-up MR imaging. The protocol included T1, T2 and contrast-enhanced (CE) T1-weighted images with fat saturation at each visit immediately for 17 months after the treatment. MR images were jointly reviewed by two radiologists, regarding the appearance of treated areas, presence of complications, and the best sequence for visualization of signal intensity (SI) changes. The therapeutic response was evaluated to be a clinical success with the relief of pain. Results: The treated areas had a target-like appearance on MR images: a central ablated zone (Z1) surrounded by a band (Z2), and a peripheral area (Z3). Z1 was a non-enhancing, hypointense core on T1, T2WI. Z2 was a well-enhancing, hyperintense rim on T2WI. Z3 was less hyperintense and less enhanced than Z2. All nidi were within Z1. This appearance became evident from 1 week to 1 and 2 months. Following up after 2 months, Z2 showed progressive inward enhancement from the periphery, resulting in almost complete enhancement of Z1 and Z2 with a diminishing size. Z3 gradually showed a decrease in signal change and enhancement. No complications were found. CE-T1WI was the best for visualizing SI changes. The clinical success was achieved in all patients except for one patient with a recurrence at 17 months following treatment that had a second ablation. Conclusion: MR imaging demonstrated a characteristic appearance and subsequent changes of treated areas for osteoid osteoma following RFA.

Original languageEnglish
Pages (from-to)309-314
Number of pages6
JournalEuropean Journal of Radiology
Volume64
Issue number2
DOIs
Publication statusPublished - 2007 Nov 1

Fingerprint

Osteoid Osteoma
Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging
Protein Sorting Signals
Therapeutics
Fats
Recurrence
Pain

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Lee, Min Hee ; Ahn, Joong Mo ; Chung, Hye Won ; Lim, Hyo K. ; Suh, Jae Gon ; Kwag, Hyon Joo ; Hong, Hyun Pyo ; Kim, Byung Moon. / Osteoid osteoma treated with percutaneous radiofrequency ablation : MR imaging follow-up. In: European Journal of Radiology. 2007 ; Vol. 64, No. 2. pp. 309-314.
@article{844d6cfdd8dc403bad3b87f108de567e,
title = "Osteoid osteoma treated with percutaneous radiofrequency ablation: MR imaging follow-up",
abstract = "Purpose: We evaluated follow-up magnetic resonance (MR) images for osteoid osteoma treated with percutaneous radiofrequency ablation (RFA). Materials and methods: Sixteen patients with osteoid osteoma treated with RFA underwent follow-up MR imaging. The protocol included T1, T2 and contrast-enhanced (CE) T1-weighted images with fat saturation at each visit immediately for 17 months after the treatment. MR images were jointly reviewed by two radiologists, regarding the appearance of treated areas, presence of complications, and the best sequence for visualization of signal intensity (SI) changes. The therapeutic response was evaluated to be a clinical success with the relief of pain. Results: The treated areas had a target-like appearance on MR images: a central ablated zone (Z1) surrounded by a band (Z2), and a peripheral area (Z3). Z1 was a non-enhancing, hypointense core on T1, T2WI. Z2 was a well-enhancing, hyperintense rim on T2WI. Z3 was less hyperintense and less enhanced than Z2. All nidi were within Z1. This appearance became evident from 1 week to 1 and 2 months. Following up after 2 months, Z2 showed progressive inward enhancement from the periphery, resulting in almost complete enhancement of Z1 and Z2 with a diminishing size. Z3 gradually showed a decrease in signal change and enhancement. No complications were found. CE-T1WI was the best for visualizing SI changes. The clinical success was achieved in all patients except for one patient with a recurrence at 17 months following treatment that had a second ablation. Conclusion: MR imaging demonstrated a characteristic appearance and subsequent changes of treated areas for osteoid osteoma following RFA.",
author = "Lee, {Min Hee} and Ahn, {Joong Mo} and Chung, {Hye Won} and Lim, {Hyo K.} and Suh, {Jae Gon} and Kwag, {Hyon Joo} and Hong, {Hyun Pyo} and Kim, {Byung Moon}",
year = "2007",
month = "11",
day = "1",
doi = "10.1016/j.ejrad.2007.06.023",
language = "English",
volume = "64",
pages = "309--314",
journal = "European Journal of Radiology",
issn = "0720-048X",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

Osteoid osteoma treated with percutaneous radiofrequency ablation : MR imaging follow-up. / Lee, Min Hee; Ahn, Joong Mo; Chung, Hye Won; Lim, Hyo K.; Suh, Jae Gon; Kwag, Hyon Joo; Hong, Hyun Pyo; Kim, Byung Moon.

In: European Journal of Radiology, Vol. 64, No. 2, 01.11.2007, p. 309-314.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Osteoid osteoma treated with percutaneous radiofrequency ablation

T2 - MR imaging follow-up

AU - Lee, Min Hee

AU - Ahn, Joong Mo

AU - Chung, Hye Won

AU - Lim, Hyo K.

AU - Suh, Jae Gon

AU - Kwag, Hyon Joo

AU - Hong, Hyun Pyo

AU - Kim, Byung Moon

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Purpose: We evaluated follow-up magnetic resonance (MR) images for osteoid osteoma treated with percutaneous radiofrequency ablation (RFA). Materials and methods: Sixteen patients with osteoid osteoma treated with RFA underwent follow-up MR imaging. The protocol included T1, T2 and contrast-enhanced (CE) T1-weighted images with fat saturation at each visit immediately for 17 months after the treatment. MR images were jointly reviewed by two radiologists, regarding the appearance of treated areas, presence of complications, and the best sequence for visualization of signal intensity (SI) changes. The therapeutic response was evaluated to be a clinical success with the relief of pain. Results: The treated areas had a target-like appearance on MR images: a central ablated zone (Z1) surrounded by a band (Z2), and a peripheral area (Z3). Z1 was a non-enhancing, hypointense core on T1, T2WI. Z2 was a well-enhancing, hyperintense rim on T2WI. Z3 was less hyperintense and less enhanced than Z2. All nidi were within Z1. This appearance became evident from 1 week to 1 and 2 months. Following up after 2 months, Z2 showed progressive inward enhancement from the periphery, resulting in almost complete enhancement of Z1 and Z2 with a diminishing size. Z3 gradually showed a decrease in signal change and enhancement. No complications were found. CE-T1WI was the best for visualizing SI changes. The clinical success was achieved in all patients except for one patient with a recurrence at 17 months following treatment that had a second ablation. Conclusion: MR imaging demonstrated a characteristic appearance and subsequent changes of treated areas for osteoid osteoma following RFA.

AB - Purpose: We evaluated follow-up magnetic resonance (MR) images for osteoid osteoma treated with percutaneous radiofrequency ablation (RFA). Materials and methods: Sixteen patients with osteoid osteoma treated with RFA underwent follow-up MR imaging. The protocol included T1, T2 and contrast-enhanced (CE) T1-weighted images with fat saturation at each visit immediately for 17 months after the treatment. MR images were jointly reviewed by two radiologists, regarding the appearance of treated areas, presence of complications, and the best sequence for visualization of signal intensity (SI) changes. The therapeutic response was evaluated to be a clinical success with the relief of pain. Results: The treated areas had a target-like appearance on MR images: a central ablated zone (Z1) surrounded by a band (Z2), and a peripheral area (Z3). Z1 was a non-enhancing, hypointense core on T1, T2WI. Z2 was a well-enhancing, hyperintense rim on T2WI. Z3 was less hyperintense and less enhanced than Z2. All nidi were within Z1. This appearance became evident from 1 week to 1 and 2 months. Following up after 2 months, Z2 showed progressive inward enhancement from the periphery, resulting in almost complete enhancement of Z1 and Z2 with a diminishing size. Z3 gradually showed a decrease in signal change and enhancement. No complications were found. CE-T1WI was the best for visualizing SI changes. The clinical success was achieved in all patients except for one patient with a recurrence at 17 months following treatment that had a second ablation. Conclusion: MR imaging demonstrated a characteristic appearance and subsequent changes of treated areas for osteoid osteoma following RFA.

UR - http://www.scopus.com/inward/record.url?scp=35348835910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348835910&partnerID=8YFLogxK

U2 - 10.1016/j.ejrad.2007.06.023

DO - 10.1016/j.ejrad.2007.06.023

M3 - Article

C2 - 17689216

AN - SCOPUS:35348835910

VL - 64

SP - 309

EP - 314

JO - European Journal of Radiology

JF - European Journal of Radiology

SN - 0720-048X

IS - 2

ER -